Sohier C
Institut Henri Beaufour, c/o Centre de Recherche Nestlé Tours, Notre Dame D'Oé, B.P. 9716, F 37097 Tours Cedex 2.
Ann Pharm Fr. 2002 Jan;60(1):22-7.
A biotechnology program on Ginkgo biloba was implemented in early 80's, in order to improve the biosynthesis in the whole plant and in cell cultures of therapeutically active substances, mainly terpenes like ginkgolides. This program led to very interesting results in various directions In addition, by the mean of in vitro culture, metabolic studies have given some pertinent fundamental results adding to the basic understanding of Ginkgo biloba: ginkgolides and bilobalide are biosynthesized in the roots of the plant and then translocated to the leaves. Two separate and independent metabolic pathways have been underlined for the formation of isopentenylpyrophosphate (IPP), the fundamental unit involved both in the biosynthesis of the sitosterol and the ginkgolides. The possibilities offered by plant biotechnology allowed the implementation of new tools for propagation and improvement of the Ginkgo biloba and have enriched the knowledge of the biosynthesis of active principles.
20世纪80年代初实施了一项关于银杏的生物技术项目,目的是提高整株植物和细胞培养物中治疗活性物质的生物合成,主要是萜类化合物如银杏内酯。该项目在多个方面取得了非常有趣的成果。此外,通过体外培养手段,代谢研究得出了一些相关的基础成果,加深了对银杏的基本认识:银杏内酯和白果内酯在植物根部生物合成,然后转运到叶片。已经明确了两条独立的代谢途径用于形成异戊烯基焦磷酸(IPP),它是参与植物甾醇和银杏内酯生物合成的基本单元。植物生物技术提供的可能性使得能够实施新的工具来繁殖和改良银杏,并丰富了活性成分生物合成的知识。